RT @neurocefalea: FUNDAMENTAL 👇 Recomendaciones sobre valproico y #migraña
RT @P_Martelletti: Dépakine scandal: indictment of the pharmaceutical group @Sanofi https://t.co/GaXICS94Xp Teratogenic and foetotoxic effe…
FUNDAMENTAL 👇 Recomendaciones sobre valproico y #migraña
RT @P_Martelletti: Dépakine scandal: indictment of the pharmaceutical group @Sanofi https://t.co/GaXICS94Xp Teratogenic and foetotoxic effe…
RT @P_Martelletti: Dépakine scandal: indictment of the pharmaceutical group @Sanofi https://t.co/GaXICS94Xp Teratogenic and foetotoxic effe…
Dépakine scandal: indictment of the pharmaceutical group @Sanofi https://t.co/GaXICS94Xp Teratogenic and foetotoxic effects of valproate and neurodevelopmental risk to children exposed to valproate in the womb. #Epilepsy #Migraine @EMA_News @EHF_Official h
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation. https://t.co/d14vXk6DDN
Valproate as #migraine treatment should be initiated with caution in women of child-bearing age. Read the full EHF-EMA consensus article: https://t.co/PUeLKND3Qb #EHF2018, @EHF_Official https://t.co/HZJex7o5FE
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @NeuroPsychBMC: #Valproate as #migraine treatment should be initiated with caution in women of child-bearing potential in view of the ri…
RT @NeuroPsychBMC: #Valproate as #migraine treatment should be initiated with caution in women of child-bearing potential in view of the ri…
RT @NeuroPsychBMC: #Valproate as #migraine treatment should be initiated with caution in women of child-bearing potential in view of the ri…
#Valproate as #migraine treatment should be initiated with caution in women of child-bearing potential in view of the risks to the foetus in the event of exposure to valproate during #pregnancy. Read the full EHF-EMA consensus article in #TJHP: https://t.c
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
RT @P_Martelletti: While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such…
While we are looking at future migraine treatments we must not forget to reduce the current use of a high-risk drug such as valproate in migraine women during their fertile age.
@EMA_news and @EHF_Official have just published a joint official Consensus on the serious risks of using vaproate in migraine women of childbearing age. #THeJournalOfHeadacheAndPain https://t.co/dnm9JtUPYd https://t.co/9UH7Pcj5If
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation https://t.co/gmVrrWOkbM https://t.co/Ge8MXA5fBj